Hepatocellular carcinoma associated with anabolic steroid therapy: Report of a case and review of the Japanese literature

Journal of Gastroenterology

Volumn 31, Issue 3, 1996, Pages 450-454

  Kosaka, Atsushi ^a   Takahashi, Hiroaki ^a   Yajima, Yukihiro ^a   Tanaka, Minoru ^a   Okamura, Kazunori ^a   Mizumoto, Ryuji ^a   Katsuta, Koji ^a  

^a Matsusaka Chuo Hospital   (Japan)

Author keywords

Anabolic steroids; Aplastic anemia; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; ANABOLIC AGENT; CARCINOEMBRYONIC ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; OXYMETHOLONE;

ADULT; APLASTIC ANEMIA; ARTICLE; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; JAPAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

ADULT; ANABOLIC AGENTS; ANEMIA, APLASTIC; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; JAPAN; LIVER; LIVER NEOPLASMS; OXYMETHOLONE; TIME FACTORS;

EID: 0029939609     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02355039     Document Type: Article

References (24)

1. Boyd PR, Mark DJ. Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years. Cancer 1977;40:1765-1770.
2. Carrasco D, Prieto M, Pallardo L, et al. Multiple hepatic adenomas after long-term therapy with testosterone enanthate. J Hepatol 1985;1:573-578.
3. Watanabe S, Kobayashi Y. Exogenous hormones and human cancer. Jpn J Clin Oncol 1993;23:1-13.
4. Stromyer FW, Smith DH, Ishak KG. Anabolic steroid therapy and intrahepatic cholangiocarcinoma. Cancer 1979;43:440-443.
5. Falk H, Thomas LB, Popper H, et al. Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet 1979;24:1120-1122.
6. Recant L, Lacy P. Fanconi's anemia and hepatic cirrhosis. Am J Med 1965;39:464-475.
7. Creagh TM, Djevans AR. Hepatic tumours induced by anabolic steroids in an athlete. J Clin Pathol 1988,41:441-443.
8. Turani H, Levi J, Zevin D, et al. Hepatic lesions in patients on anabolic androgenic therapy. Isr J Med Sci 1983;19:332-337.
9. Oda K, Oguma N, Kawano M, et al. Hepatocellular carcinoma associated with long-term anabolic steroid therapy in two patients with aplastic anemia. Acta Haematol Jpn 1987;50:29-36.
10. Neuberger J, Forman D, Doll R, et al. Oral contraceptives and hepatocellular carcinoma. Br Med J 1986;292:1357-1361.
11. Tao LC. Are oral contraceptive-associated liver cell adenomas premalignant? Acta Cytol 1992;36:338-344.
12. Higashi S, Tomita T, Mizumoto R, et al. Development of hepatoma in rats following oral administration of synthetic estrogen and progestogen. Gann 1980;71:576-577.
13. Tanigawa K. Experimental studies on hepatocarcinogenesis of synthetic estrogen and progestogen with special reference to progression and biological characteristics of the developed hepatocellular carcinoma (in Japanese). Acta Hepatol Jpn 1989; 30:985-994.
14. Horii K, Yasui M, Adachi Y, et al. An autopsy case of primary hepatoma associated with an oral contraceptive. Hepatogastroenterology 1982;29:187-190.
15. Touraine RL, Bertrand Y, Foray P, et al. Hepatic tumours during androgen therpay in Fanconi's anemia. Eur J Pediatr 1993; 152:691-693.
16. Ichida F, Kawamura T. Liver cirrhosis (in Japanese). Jpn J Clin Med 1983;41:551-558.
17. Westby D, Portmann B, Williams R. Androgen-related primary hepatic tumors in non-Fanconi's patients. Cancer 1983;51:1947-1952.
18. Farrell GC, Joshua DE, Uren RF, et al. Androgen-induced hepatoma. Lancet 1975;2:430-432.
19. McCaughan GW, Bilous MJ, Gallagher ND. Long-term survival with tumor regression in androgen-induced liver tumors. Cancer 1985;56:2622-2626.
20. Montgomery PR, Ducore JM, Githens JH, et al. Regression of oxymetholone-induced hepatic tumors after bone marrow transplantation in aplastic anemia. Transplantation 1980;30:90-96.
21. Foster JH, Berman MM. The malignant transformation of liver cell adenomas Arch Surg 1994;129:712-717.
22. Nagasue N, Kohno H, Chang YC, et al. Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women. Cancer 1988;63:112-116.
23. Wilson JD, Griffin JE. The use and misuse of androgens. Metabolism 1988;29:1278-1295.
24. Yamagishi M, Hiraoka A, Uchino H. Silent hepatic lesions detected with computed tomography in aplastic anemia patients administered androgens for a long period. Acta Haematol Jpn 1982;45:703-710